Literature DB >> 7825604

Two new cases of FMR1 deletion associated with mental impairment.

M Hirst1, P Grewal, A Flannery, R Slatter, E Maher, D Barton, J P Fryns, K Davies.   

Abstract

Screening of families clinically ascertained for the fragile X syndrome phenotype revealed two mentally impaired males who were cytogenetically negative for the fragile X chromosome. In both cases, screening for the FMR1 trinucleotide expansion mutation revealed a rearrangement within the FMR1 gene. In the first case, a 660-bp deletion is present in 40% of peripheral lymphocytes. PCR and sequence analysis revealed it to include the CpG island and the CGG trinucleotide repeat, thus removing the FMR1 promoter region and putative mRNA start site. In the second case, PCR analysis demonstrated that a deletion extended from a point proximal to FMR1 to 25 kb into the gene, removing all the region 5' to exon 11. The distal breakpoint was confirmed by Southern blot analysis and localized to a 600-bp region, and FMR1-mRNA analysis in a cell line established from this individual confirmed the lack of a transcript. These deletion patients provide further confirmatory evidence that loss of FMR1 gene expression is indeed responsible for mental retardation. Additionally, these cases highlight the need for the careful examination of the FMR1 gene, even in the absence of cytogenetic expression, particularly when several fragile X-like clinical features are present.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7825604      PMCID: PMC1801332     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  31 in total

1.  KH domains within the FMR1 sequence suggest that fragile X syndrome stems from a defect in RNA metabolism.

Authors:  T J Gibson; P M Rice; J D Thompson; J Heringa
Journal:  Trends Biochem Sci       Date:  1993-09       Impact factor: 13.807

2.  In vitro DNA methylation inhibits FMR-1 promoter.

Authors:  W L Hwu; Y M Lee; S C Lee; T R Wang
Journal:  Biochem Biophys Res Commun       Date:  1993-05-28       Impact factor: 3.575

3.  Dinucleotide repeat polymorphism close to IDS gene in Xq27.3-q28 (DXS1113).

Authors:  C Weber; C Oudet; S Johnson; G Pilia; D Schlessinger; A Hanauer
Journal:  Hum Mol Genet       Date:  1993-05       Impact factor: 6.150

4.  Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain.

Authors:  M Abitbol; C Menini; A L Delezoide; T Rhyner; M Vekemans; J Mallet
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

5.  Abnormal pattern detected in fragile-X patients by pulsed-field gel electrophoresis.

Authors:  A Vincent; D Heitz; C Petit; C Kretz; I Oberlé; J L Mandel
Journal:  Nature       Date:  1991-02-14       Impact factor: 49.962

6.  Fine structure of the human FMR1 gene.

Authors:  E E Eichler; S Richards; R A Gibbs; D L Nelson
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

7.  The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation.

Authors:  D Devys; Y Lutz; N Rouyer; J P Bellocq; J L Mandel
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

8.  Molecular analysis of a ring chromosome X in a family with fragile X syndrome.

Authors:  E Mornet; A Bogyo; C Deluchat; B Simon-Bouy; M Mathieu; F Thépot; M C Grisard; E Leguern; J Boué; A Boué
Journal:  Hum Genet       Date:  1993-10       Impact factor: 4.132

9.  Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat.

Authors:  C T Ashley; J S Sutcliffe; C B Kunst; H A Leiner; E E Eichler; D L Nelson; S T Warren
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

10.  Origins of the fragile X syndrome mutation.

Authors:  M C Hirst; S J Knight; Z Christodoulou; P K Grewal; J P Fryns; K E Davies
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

View more
  24 in total

Review 1.  Mutation spectra in fragile X syndrome induced by deletions of CGG*CCG repeats.

Authors:  Robert D Wells
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

2.  Small genomic rearrangements involving FMR1 support the importance of its gene dosage for normal neurocognitive function.

Authors:  Sandesh C S Nagamani; Ayelet Erez; Frank J Probst; Patricia Bader; Patricia Evans; Linda A Baker; Ping Fang; Terry Bertin; Patricia Hixson; Pawel Stankiewicz; David Nelson; Ankita Patel; Sau Wai Cheung
Journal:  Neurogenetics       Date:  2012-08-14       Impact factor: 2.660

3.  Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes.

Authors:  Y Feng; C A Gutekunst; D E Eberhart; H Yi; S T Warren; S M Hersch
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

4.  Familial transmission of the FMR1 CGG repeat.

Authors:  S L Nolin; F A Lewis; L L Ye; G E Houck; A E Glicksman; P Limprasert; S Y Li; N Zhong; A E Ashley; E Feingold; S L Sherman; W T Brown
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

Review 5.  Clinically relevant known and candidate genes for obesity and their overlap with human infertility and reproduction.

Authors:  Merlin G Butler; Austen McGuire; Ann M Manzardo
Journal:  J Assist Reprod Genet       Date:  2015-01-29       Impact factor: 3.412

Review 6.  Fragile X syndrome. Molecular and clinical insights and treatment issues.

Authors:  R J Hagerman
Journal:  West J Med       Date:  1997-02

7.  The fragile x mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge.

Authors:  François Rousseau; Yves Labelle; Johanne Bussières; Carmen Lindsay
Journal:  Clin Biochem Rev       Date:  2011-08

8.  A MicroRNA Profile in Fmr1 Knockout Mice Reveals MicroRNA Expression Alterations with Possible Roles in Fragile X Syndrome.

Authors:  Ting Liu; Rui-Ping Wan; Ling-Jia Tang; Shu-Jing Liu; Hai-Jun Li; Qi-Hua Zhao; Wei-Ping Liao; Xiao-Fang Sun; Yong-Hong Yi; Yue-Sheng Long
Journal:  Mol Neurobiol       Date:  2014-06-07       Impact factor: 5.590

9.  Deletion of all CGG repeats plus flanking sequences in FMR1 does not abolish gene expression.

Authors:  K Grønskov; H Hjalgrim; M O Bjerager; K Brøndum-Nielsen
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

Review 10.  Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: a case report and review of the literature.

Authors:  Bradford Coffee; Morna Ikeda; Dejan B Budimirovic; Lawrence N Hjelm; Walter E Kaufmann; Stephen T Warren
Journal:  Am J Med Genet A       Date:  2008-05-15       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.